Joel M Reid, PhD

  • 7571 Citations
  • 45 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 7571 Citations
  • 45 Scopus h-Index
  • 171 Article
  • 2 Comment/debate
  • 2 Letter
Filter
Article
2007

Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide

Myers, R. M., Greiner, S. M., Harvey, M. E., Griesmann, G., Kuffel, M. J., Buhrow, S. A., Reid, J. M., Federspiel, M., Ames, M. M., Dingli, D., Schweikart, K., Welch, A., Dispenzieri, A., Peng, K. W. & Russell, S. J., Dec 1 2007, In : Clinical pharmacology and therapeutics. 82, 6, p. 700-710 11 p.

Research output: Contribution to journalArticle

88 Scopus citations
2006

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

Pilot, H. C., Adjei, A. A., Reid, J. M., Sloan, J. A., Atherton, P. J., Rubin, J., Alberts, S. R., Duncan, B. A., Denis, L., Schaaf, L. J., Yin, D., Sharma, A., McGovren, P., Miller, L. L. & Erlichman, C., Aug 1 2006, In : Cancer chemotherapy and pharmacology. 58, 2, p. 165-172 8 p.

Research output: Contribution to journalArticle

14 Scopus citations

A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors

Delaunoit, T., Burch, P. A., Reid, J. M., Camoriano, J. K., Kobayash, T., Braich, T. A., Kaur, J. S., Rubin, J. & Erlichman, C., Jul 1 2006, In : Investigational New Drugs. 24, 4, p. 327-333 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer

Nowakowski, G. S., McCollum, A. K., Ames, M. M., Mandrekar, S. J., Reid, J. M., Adjei, A. A., Toft, D. O., Safgren, S. L. & Erlichman, C., Oct 15 2006, In : Clinical Cancer Research. 12, 20 PART 1, p. 6087-6093 7 p.

Research output: Contribution to journalArticle

100 Scopus citations

LC-MS/MS assay and dog pharmacokinetics of the dimeric pyrrolobenzodiazepine SJG-136 (NSC 694501)

Buhrow, S. A., Reid, J. M., Jia, L., McGovern, R. M., Covey, J. M., Kobs, D. J., Grossi, I. M. & Ames, M. M., Aug 7 2006, In : Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 840, 1, p. 56-62 7 p.

Research output: Contribution to journalArticle

10 Scopus citations

Phase I trial of oral fenretinide in children with high-risk solid tumors: A report from the children's oncology group (CCG 09709)

Villablanca, J. G., Krailo, M. D., Ames, M. M., Reid, J. M., Reaman, G. H. & Reynolds, P. C., Jul 20 2006, In : Journal of Clinical Oncology. 24, 21, p. 3423-3430 8 p.

Research output: Contribution to journalArticle

112 Scopus citations

Synthesis of novel caspase inhibitors for characterization of the active caspase proteome in vitro and in vivo

Henzing, A. J., Dodson, H., Reid, J. M., Kaufmann, S. H., Baxter, R. L. & Earnshaw, W. C., Dec 28 2006, In : Journal of Medicinal Chemistry. 49, 26, p. 7636-7645 10 p.

Research output: Contribution to journalArticle

8 Scopus citations
2005

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin

Molina, J. R., Reid, J. M., Erlichman, C., Sloan, J. A., Furth, A., Safgren, S. L., Lathia, C. D. & Alberts, S. R., Oct 1 2005, In : Anti-cancer drugs. 16, 9, p. 997-1002 6 p.

Research output: Contribution to journalArticle

21 Scopus citations

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

Dy, G. K., Suri, A., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Atherton, P. J., Hanson, L. J., Burch, P. A., Rubin, J., Erlichman, C. & Adjei, A. A., Jun 1 2005, In : Cancer chemotherapy and pharmacology. 55, 6, p. 522-530 9 p.

Research output: Contribution to journalArticle

22 Scopus citations

A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer

Dy, G. K., Bruzek, L. M., Croghan, G. A., Mandrekar, S., Erlichman, C., Peethambaram, P., Pitot, H. C., Hanson, L. J., Reid, J. M., Furth, A., Cheng, S., Martell, R. E., Kaufmann, S. H. & Adjei, A. A., Mar 1 2005, In : Clinical Cancer Research. 11, 5, p. 1877-1883 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

Phase 1 trial of flavopiridol combined with cisplatin or carboplatin in patients with advanced malignancies with the assessment of pharmacokinetic and pharmacodynamic end points

Bible, K. C., Lensing, J. L., Nelson, S. A., Lee, Y. K., Reid, J. M., Ames, M. M., Isham, C. R., Piens, J., Rubin, S. L., Rubin, J., Kaufmann, S. H., Atherton, P. J., Sloan, J. A., Daiss, M. K., Adjei, A. A. & Erlichman, C., Aug 15 2005, In : Clinical Cancer Research. 11, 16, p. 5935-5941 7 p.

Research output: Contribution to journalArticle

56 Scopus citations

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial

Galanis, E., Buckner, J. C., Maurer, M. J., Reid, J. M., Kuffel, M. J., Ames, M. M., Scheithauer, B. W., Hammack, J. E., Pipoly, G. & Kuross, S. A., Oct 1 2005, In : Investigational New Drugs. 23, 5, p. 495-503 9 p.

Research output: Contribution to journalArticle

18 Scopus citations

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies

LoRusso, P. M., Adjei, A. A., Varterasian, M., Gadgeel, S., Reid, J., Mitchell, D. Y., Hanson, L., DeLuca, P., Bruzek, L., Piens, J., Asbury, P., Van Becelaere, K., Herrera, R., Sebolt-Leopold, J. & Meyer, M. B., Dec 1 2005, In : Journal of Clinical Oncology. 23, 23, p. 5281-5293 13 p.

Research output: Contribution to journalArticle

312 Scopus citations

Phase I and pharmacologic study of infusional topotecan and carboplatin in relapsed and refractory acute leukemia

Kaufmann, S. H., Karp, J. E., Letendre, L., Kottke, T. J., Safgren, S., Greer, J., Gojo, I., Atherton, P., Svingen, P. A., Loegering, D. A., Litzow, M. R., Sloan, J. A., Reid, J. M., Ames, M. M., Adjei, A. A. & Erlichman, C., Sep 15 2005, In : Clinical Cancer Research. 11, 18, p. 6641-6649 9 p.

Research output: Contribution to journalArticle

26 Scopus citations

Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: A Children's Oncology Group Study

Whitlock, J. A., Krailo, M., Reid, J. M., Ruben, S. L., Ames, M. M., Owen, W. & Reaman, G., Dec 1 2005, In : Journal of Clinical Oncology. 23, 36, p. 9179-9186 8 p.

Research output: Contribution to journalArticle

29 Scopus citations

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

Goetz, M. P., Toft, D., Reid, J., Ames, M., Stensgard, B., Safgren, S., Adjei, A. A., Sloan, J., Atherton, P., Vasile, V., Salazaar, S., Adjei, A., Croghan, G. & Erlichman, C., Feb 20 2005, In : Journal of Clinical Oncology. 23, 6, p. 1078-1087 10 p.

Research output: Contribution to journalArticle

300 Scopus citations
2004

Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors

Reid, J. M., Qu, W., Safgren, S. L., Ames, M. M., Krailo, M. D., Seibel, N. L., Kuttesch, J. & Holcenberg, J., Dec 1 2004, In : Journal of Clinical Oncology. 22, 12, p. 2445-2451 7 p.

Research output: Contribution to journalArticle

64 Scopus citations

The Metabolism of Pyrazoloacridine (NSC 366140) by Cytochromes P450 and Flavin Monooxygenase in Human Liver Microsomes

Reid, J. M., Walker, D. L., Miller, J. K., Benson, L. M., Tomlinson, A. J., Naylor, S., Blajeski, A. L., LoRusso, P. M. & Ames, M. M., Feb 15 2004, In : Clinical Cancer Research. 10, 4, p. 1471-1480 10 p.

Research output: Contribution to journalArticle

21 Scopus citations
2003

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer

Adjei, A. A., Dy, G. K., Erlichman, C., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P. J., Watanabe, T., Geary, R. S., Holmlund, J. & Dorr, F. A., Jan 1 2003, In : Clinical Cancer Research. 9, 1 I, p. 115-123 9 p.

Research output: Contribution to journalArticle

76 Scopus citations

A phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

Adjei, A. A., Croghan, G. A., Erlichman, C., Marks, R. S., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Bruzek, L. M., Atherton, P., Thibault, A., Palmer, P. A. & Kaufmann, S. H., Jul 1 2003, In : Clinical Cancer Research. 9, 7, p. 2520-2526 7 p.

Research output: Contribution to journalArticle

47 Scopus citations

Irinotecan in the treatment of glioma patients: Current and future studies of the North Central Cancer Treatment Group

Buckner, J. C., Reid, J. M., Wright, K., Kaufmann, S. H., Erlichman, C., Ames, M., Cha, S., O'Fallon, J. R., Schaaf, L. J. & Miller, L. L., May 1 2003, In : Cancer. 97, 9 SUPPL., p. 2352-2358 7 p.

Research output: Contribution to journalArticle

36 Scopus citations

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, fluorouracil, and leucovorin in patients with solid tumors

Goetz, M. P., Erlichman, C., Windebank, A. J., Reid, J. M., Sloan, J. A., Atherton, P., Adjei, A. A., Rubin, J., Pitot, H., Galanis, E., Ames, M. M. & Goldberg, R. M., Oct 15 2003, In : Journal of Clinical Oncology. 21, 20, p. 3761-3769 9 p.

Research output: Contribution to journalArticle

38 Scopus citations

Single-dose pharmacokinetics of the DNA-binding bioreductive agent NLCQ-1 (NSC 709257) in CD2F1 mice

Reid, J. M., Squillace, D. P. & Ames, M. M., Jun 1 2003, In : Cancer chemotherapy and pharmacology. 51, 6, p. 483-487 5 p.

Research output: Contribution to journalArticle

11 Scopus citations
2002

Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2

Kuffel, M. J., Schroeder, J. C., Pobst, L. J., Naylor, S., Reid, J. M., Kaufmann, S. H. & Ames, M. M., Jul 4 2002, In : Molecular pharmacology. 62, 1, p. 143-153 11 p.

Research output: Contribution to journalArticle

55 Scopus citations

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

Adjei, A. A., Reid, J. M., Erlichman, C., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Ruben, S., Boerner, S. A., Atherton, P., Ames, M. M. & Kaufmann, S. H., Aug 8 2002, In : Investigational New Drugs. 20, 3, p. 297-304 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors

Pitot, H. C., Reid, J. M., Sloan, J. A., Ames, M. M., Adjei, A. A., Rubin, J., Bagniewski, P. G., Atherton, P., Rayson, D., Goldberg, R. M. & Erlichman, C., Jul 18 2002, In : Clinical Cancer Research. 8, 3, p. 712-717 6 p.

Research output: Contribution to journalArticle

28 Scopus citations

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

Adjei, A. A., Reid, J. M., Diasio, R. B., Sloan, J. A., Smith, D. A., Rubin, J., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P., Ames, M. M. & Erlichman, C., Mar 15 2002, In : Journal of Clinical Oncology. 20, 6, p. 1683-1691 9 p.

Research output: Contribution to journalArticle

28 Scopus citations

Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed on refractory leukemia (CCG-0955): A report from the children's cancer group

Steinherz, P. G., Seibel, N. L., Ames, M. M., Avramis, V. I., Krailo, M. D., Liu-Mares, W., Reid, J. M., Safgren, S. L. & Reaman, G. H., Oct 1 2002, In : Leukemia and Lymphoma. 43, 10, p. 1945-1950 6 p.

Research output: Contribution to journalArticle

20 Scopus citations

Phase i trial of cisplatin and topotecan in children with recurrent solid tumors: Children’s cancer group study 0942

Wells, R. J., Reid, J. M., Ames, M. M., Mares, W. L., Krailo, M. D., Seibel, N. L., Mosher, R., Reaman, G. H. & Wiersma, S. R., Jan 1 2002, In : American Journal of Pediatric Hematology/Oncology. 24, 2, p. 89-93 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide

Klein, C. E., Gupta, E., Reid, J. M., Atherton, P. J., Sloan, J. A., Pitot, H. C., Ratain, M. J. & Kastrissios, H., Dec 1 2002, In : Clinical pharmacology and therapeutics. 72, 6, p. 638-647 10 p.

Research output: Contribution to journalArticle

52 Scopus citations

Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans

Reid, J. M., Kuffel, M. J., Ruben, S. L., Morales, J. J., Rinehart, K. L., Squillace, D. P. & Ames, M. M., Sep 2002, In : Clinical Cancer Research. 8, 9, p. 2952-2962 11 p.

Research output: Contribution to journalArticle

42 Scopus citations
2001

A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities

Bracho, F., Krailo, M. D., Shen, V., Bergeron, S., Davenport, V., Liu-Mares, W., Blazar, B. R., Panoskaltsis-Mortari, A., Van De Ven, C., Secola, R., Ames, M. M., Reid, J. M., Reaman, G. H. & Cairo, M. S., Jan 2001, In : Clinical Cancer Research. 7, 1, p. 58-67 10 p.

Research output: Contribution to journalArticle

15 Scopus citations

Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide

Sloan, J. A., Atherton, P., Reid, J., Pitot, H. C., Erlichman, C. & Schaaf, L., Jan 1 2001, In : Cancer chemotherapy and pharmacology. 48, 3, p. 241-249 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2′-deoxyuridine (IdUrd)

Galanis, E., Goldberg, R., Reid, J., Atherton, P., Sloan, J., Pitot, H., Rubin, J., Adjei, A. A., Burch, P., Safgren, S. L., Witzig, T. E., Ames, M. M. & Erlichman, C., Jun 21 2001, In : Annals of Oncology. 12, 5, p. 701-707 7 p.

Research output: Contribution to journalArticle

4 Scopus citations
19 Scopus citations
2000

A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma

Rajkumar, V. S., Reid, J. M., Novotny, P. J., Safgren, S. L., Scheithauer, B. W., Johnson, S. P., Nair, S., Morton, R. F., Hatfield, A. K., Krook, J. E., Ames, M. M. & Buckner, J. C., Dec 1 2000, In : Journal of neuro-oncology. 49, 3, p. 255-261 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury in vivo

Mruk, J. S., Webster, M. W. I., Heras, M., Reid, J. M., Grill, D. E. & Chesebro, J. H., Jan 25 2000, In : Circulation. 101, 3, p. 324-328 5 p.

Research output: Contribution to journalArticle

Open Access
22 Scopus citations

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity

Adjei, A. A., Klein, C. E., Kastrissios, H., Goldberg, R. M., Alberts, S. R., Pitot, H. C., Sloan, J. A., Reid, J. M., Hanson, L. J., Atherton, P., Rubin, J. & Erlichman, C., Mar 1 2000, In : Journal of Clinical Oncology. 18, 5, p. 1116-1123 8 p.

Research output: Contribution to journalArticle

54 Scopus citations

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors

Adjei, A. A., Erlichman, C., Sloan, J. A., Reid, J. M., Pitot, H. C., Goldberg, R. M., Peethambaram, P., Atherton, P., Hanson, L. J., Alberts, S. R. & Jett, J., Apr 2000, In : Journal of Clinical Oncology. 18, 8, p. 1748-1757 10 p.

Research output: Contribution to journalArticle

116 Scopus citations

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy

Pitot, H. C., Goldberg, R. M., Reid, J. M., Sloan, J. A., Skaff, P. A., Erlichman, C., Rubin, J., Burch, P. A., Adjei, A. A., Alberts, S. A., Schaaf, L. J., Elfring, G. & Miller, L. L., Jun 1 2000, In : Clinical Cancer Research. 6, 6, p. 2236-2244 9 p.

Research output: Contribution to journalArticle

76 Scopus citations
1999

Limited sampling models for irinotecan pharmacokinetics

Sloan, J. A., Skaff, P. A., Reid, J., Pilot, H., Erlichman, C. & Schaaf, L., Jan 1 1999, In : Clinical pharmacology and therapeutics. 65, 2, 1 p.

Research output: Contribution to journalArticle

1 Scopus citations

Metabolic activation of dacarbazine by human cytochromes P450: The role of CYP1A1, CYP1A2, and CYP2E1

Reid, J. M., Kuffel, M. J., Miller, J. K., Rios, R. & Ames, M. M., Aug 1 1999, In : Clinical Cancer Research. 5, 8, p. 2192-2197 6 p.

Research output: Contribution to journalArticle

97 Scopus citations

Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent

Walker, D. L., Reid, J. M., Svingen, P. A., Rios, R., Covey, J. M., Alley, M. C., Hollingshead, M. G., Budihardjo, I. I., Eckdahl, S., Boerner, S. A., Kaufmann, S. H. & Ames, M. M., Sep 15 1999, In : Biochemical Pharmacology. 58, 6, p. 1057-1066 10 p.

Research output: Contribution to journalArticle

22 Scopus citations

Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model

Berg, S. L., Reid, J., Godwin, K., Murry, D. J., Poplack, D. G., Balis, F. M. & Ames, M. M., Jan 1 1999, In : Journal of Pediatric Hematology/Oncology. 21, 1, p. 26-30 5 p.

Research output: Contribution to journalArticle

12 Scopus citations

Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma

Buckner, J. C., Malkin, M. G., Reed, E., Cascino, T. L., Reid, J. M., Ames, M. M., Tong, W. P. Y., Lim, S. & Figg, W. D., Jan 1 1999, In : Mayo Clinic proceedings. 74, 2, p. 137-145 9 p.

Research output: Contribution to journalArticle

29 Scopus citations

Phase I study of topotecan administered as a 21-day continuous infusion in children with recurrent solid tumors: A report from the children's cancer group

Frangoul, H., Ames, M. M., Mosher, R. B., Reid, J. M., Krailo, M. D., Seibel, N. L., Shaw, D. W. W., Steinherz, P. G., Whitlock, J. A. & Holcenberg, J. S., Dec 1 1999, In : Clinical Cancer Research. 5, 12, p. 3956-3962 7 p.

Research output: Contribution to journalArticle

43 Scopus citations

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors

Pitot, H. C., McElroy, E. A., Reid, J. M., Windebank, A. J., Sloan, J. A., Erlichman, C., Bagniewski, P. G., Walker, D. L., Rubin, J., Goldberg, R. M., Adjei, A. A. & Ames, M. M., Mar 1 1999, In : Clinical Cancer Research. 5, 3, p. 525-531 7 p.

Research output: Contribution to journalArticle

100 Scopus citations
1998

6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin

Budihardjo, I. I., Walker, D. L., Svingen, P. A., Buckwalter, C. A., Desnoyers, S., Eckdahl, S., Shah, G. M., Poirier, G. G., Reid, J. M., Ames, M. M. & Kaufmann, S. H., Jan 1 1998, In : Clinical Cancer Research. 4, 1, p. 117-130 14 p.

Research output: Contribution to journalArticle

41 Scopus citations

Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer

Reid, J. M., Kovach, J. S., O'Connell, M. J., Bagniewski, P. G. & Moertel, C. G., Apr 8 1998, In : Cancer chemotherapy and pharmacology. 41, 6, p. 477-484 8 p.

Research output: Contribution to journalArticle

26 Scopus citations

Effect of Pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II

Adjei, A. A., Charron, M., Rowinsky, E. K., Svingen, P. A., Miller, J., Reid, J. M., Sebolt-Leopold, J., Ames, M. M. & Kaufmann, S. H., Mar 1998, In : Clinical Cancer Research. 4, 3, p. 683-691 9 p.

Research output: Contribution to journalArticle

46 Scopus citations